Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer. (nature.com)

Authors: Gibson V … Cunniff B Journal: Nature Communications Published: 2026-07-14 DOI: https://doi.org/10.1038/s41467-026-75153-y